US medtech stocks fall as Trump administration opens import probe

Core Viewpoint - U.S. medtech stocks experienced a decline following the U.S. Commerce Department's initiation of a probe into medical device imports, which may result in tariffs [1] Group 1 - The U.S. Commerce Department's investigation into medical device imports could impact the financial performance of companies in the medtech sector [1] - The potential for tariffs on imported medical devices raises concerns about increased costs for companies reliant on foreign manufacturing [1]